Product Description
Smart pills are essentially ingestible sensors that are swallowed and can record various physiological measures. They can also be used to confirm that a patient has taken his or her prescribed medication, and can measure the effects of the medication.Biology Smart Pills mainly refer to the smart pills with biology technology.
The Biology Smart Pills market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Biology Smart Pills market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Biology Smart Pills Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Biology Smart Pills market are:
Medimetrics
Capsovision
Cerner Corporation
Fujifilm Holdings Corporation
Ge Healthcare
Boston Scientific Corporation
Proteus Digital Health
Bio –Images Research
Pentax Medical Company
Olympus Corporation
Acamp
Given Imaging
Karl Storz Gmbh & Co. KG
Most important types of Biology Smart Pills products covered in this report are:
Capsule Endoscopy
Drug Delivery
Patient Monitoring
Most widely used downstream fields of Biology Smart Pills market covered in this report are:
Esophagus
Stomach
Small Intestine
Large Intestine
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.